Atrial fibrillation, stroke prevention, coumarines atriumfinrilleren, CVA preventie, coumarines
Conditions
Interventions
Decision support messages that alert the physician about issues with the antithrombotic treatment used for their current patient (active on screen). Positive feedback when current treatment is accordi
2. Arm 2 receives messages but will not be obliged to answer and can ignore messages without giving an explanation
3. Arm 3 will be able to ignore messages but when GPs do they will be required to provide a reason. They cannot continue with other patients before they provide a reason. This way we hope to gather da
Sponsors
Amsterdam Medical Center
Eligibility
Inclusion criteria
Inclusion criteria: Patients: All patients with atrial fibrillation enlisted in general practitice. Physicians: All primary care physicians in the GAZO centers and other GPs, consenting in participation.
Exclusion criteria
Exclusion criteria: N/A
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of patients with non-valvular atrial fibrillation whose anti-thrombotic treatment prescription is in accordance with the Dutch NHG guideline. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reasons GPs report to deviate from the given advice (/guideline). | — |
Contacts
Public ContactDiederick L. Arts
Meibergdreef 9
Outcome results
None listed